As rising drug prices became a hot political issue, Yvanna Cancela was looking for a way to make a difference. So early last year, the Nevada state senator introduced a transparency bill that would require drugmakers to report pricing, costs, and rebates—but only concerning diabetes medications.
According to a new study completed by the American Diabetes Association, the total cost of diagnosed diabetes for 2017 was estimated at $327 billion.
The American Diabetes Association (ADA) has issued a public policy statement that outlines long- and short-term recommendations for improving insulin affordability.
Alec Smith was diagnosed with type 1 diabetes shortly before his 24th birthday. When he turned 26, he lost his health insurance. Less than a month later, he lost his life because he couldn’t afford the exorbitant price of his life-saving insulin.
The American Diabetes Association (ADA) released a set of policy recommendations designed to spotlight the increasing difficulties patients with diabetes have affording insulin or gaining access to the life-saving medication through health insurance.
In a new policy statement, the American Diabetes Association (ADA) provides specific short- and long-term recommendations for improving insulin access and affordability.
Jack Lafferty has needed insulin for about 10 years. With insulin prices skyrocketing in the U.S., it’s taking a toll on monthly medical bills.
The increasing cost and access to insulin has become a great concern to individuals with diabetes, as well as all other stakeholders, including families, healthcare providers, insurers, and employers, and the American Diabetes Association (ADA) has now issued a white paper addressing the subject.
More than 100 million Americans live with diabetes or pre-diabetes according to the CDC, and some can’t afford the testing supplies and medication they need to live healthy lives.
The debate about drug costs can be hard to follow because it is both broad and deep. Between patients not being able to afford their medication, the role of “middlemen” (pharmacy benefit managers), and lawyers filing class-action lawsuits, the topic is complex and can be emotional for many.
Alec Raeshawn Smith, 26, was trying to hold out for payday so he could afford to pick up his insulin prescription. But Smith, a type 1 diabetic, was found dead in his apartment before payday arrived.
When Alec Smith turned 26 last May and aged out of his parents’ health insurance, he discovered that he couldn’t afford coverage of his own. Within weeks, he was trying to ration his diabetes medication because he couldn’t afford a $1,300 refill.